{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:35Z","timestamp":1790753855271,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.critrevonc.2022.103640","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:42:29Z","timestamp":1645130549000},"page":"103640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A bone paradigm challenging the standard model of myeloma oncogenesis"],"prefix":"10.1016","volume":"172","author":[{"given":"Jean-Pascal","family":"Capp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103640_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jbo.2018.09.001","article-title":"Osteoblast suppression in multiple myeloma bone disease","volume":"13","author":"Adamik","year":"2018","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.critrevonc.2022.103640_bib2","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","article-title":"Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease","volume":"7","author":"Bataille","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103640_bib3","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","article-title":"Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies","volume":"87","author":"Bataille","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2022.103640_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.clml.2013.07.003","article-title":"Multiple myeloma international staging system: \u201cstaging\u201d or simply \u201caging\u201d system?","volume":"13","author":"Bataille","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.critrevonc.2022.103640_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/bies.20326","article-title":"Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development","volume":"27","author":"Capp","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.critrevonc.2022.103640_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/bies.201100149","article-title":"Stochastic gene expression stabilization as a new therapeutic strategy for cancer","volume":"34","author":"Capp","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.critrevonc.2022.103640_bib7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/ijc.30596","article-title":"Tissue disruption increases stochastic gene expression thus producing tumors: cancer initiation without driver mutation","volume":"140","author":"Capp","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103640_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fonc.2018.00355","article-title":"Multiple myeloma exemplifies a model of cancer based on tissue disruption as the initiator event","volume":"8","author":"Capp","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103640_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082158","article-title":"Multiple myeloma as a bone disease? The tissue disruption-induced cell stochasticity (TiDiS) theory","volume":"12","author":"Capp","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2022.103640_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fcell.2020.00659","article-title":"A darwinian and physical look at stem cell biology helps understanding the role of stochasticity in development","volume":"8","author":"Capp","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2022.103640_bib11","article-title":"Tissue-disruption-induced cellular stochasticity and epigenetic drift: common origins of aging and cancer?","volume":"43","author":"Capp","year":"2020","journal-title":"Bioessays"},{"key":"10.1016\/j.critrevonc.2022.103640_bib12","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jbmr.2387","article-title":"unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?","volume":"29","author":"Drake","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.critrevonc.2022.103640_bib13","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/s41375-020-01051-x","article-title":"Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","volume":"34","author":"Ho","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2022.103640_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103640_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2004.02.131","article-title":"Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL\/KaLwRij mouse","volume":"316","author":"Libouban","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2022.103640_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.celrep.2015.12.016","article-title":"Stromal-initiated changes in the bone promote metastatic niche development","volume":"14","author":"Luo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2022.103640_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"Mendez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103640_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103640_bib19","article-title":"Bisphosphonates in multiple myeloma: an updated network meta-analysis","volume":"12","author":"Mhaskar","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.critrevonc.2022.103640_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in gaucher disease: the role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2022.103640_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2022.103640_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/jci.insight.98259","article-title":"Antigen-mediated regulation in monoclonal gammopathies and myeloma","volume":"3","author":"Nair","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2022.103640_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2020.01.009","article-title":"Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy","volume":"129","author":"Nair","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.critrevonc.2022.103640_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21041247","article-title":"Immunoglobulin abnormalities in gaucher disease: an analysis of 278 patients included in the French gaucher disease registry","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2022.103640_bib25","first-page":"5296","article-title":"Cancers beget mutations versus mutations beget cancers","volume":"54","author":"Prehn","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103640_bib26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2022.103640_bib27","first-page":"2935","article-title":"Cancer as a dynamic developmental disorder","volume":"45","author":"Rubin","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2022.103640_bib28","first-page":"799","article-title":"Selected cell and selective microenvironment in neoplastic development","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103640_bib29","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/eva.13039","article-title":"The role of host environment in cancer evolution","volume":"13","author":"Solary","year":"2020","journal-title":"Evol. Appl."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:41:55Z","timestamp":1760902915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822000646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"alternative-id":["S1040842822000646"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103640","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bone paradigm challenging the standard model of myeloma oncogenesis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103640"}}